Effectiveness and Safety of Acupuncture for Obesity and Over-weight People

Not Applicable

• Conditions: Obesity; Overweight

• Registration Number: NCT02108236
• Lead Sponsor: Heilongjiang University of Chinese Medicine

Brief Summary

To determine the efficacy and safety of acupuncture for obesity and overweight people in China.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-03-30
• Study First Submitted QC: 2014-04-08
• Study First Posted: 2014-04-09
• Study Start: 2014-05
• Status Verified: 2015-03
• Last Update Submitted: 2015-03-25
• Last Update Posted: 2015-03-26
• Primary Completion: 2015-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 110

Inclusion Criteria

• The individuals is phlegm-dampness constitution and female.
• Age is between 18 and 45 years.
• BMI is between 24 and 50.
• The individuals voluntarily sign the informed consent form.
• The individuals live in Harbin City of China.

Exclusion Criteria

• Secondary obesity, eg:pituitary diseases, hypothalamic disorder, hypothyroidism, pancreatic diseases，hyperadrenocorticism, postmenopausal obesity etc.
• The individuals with server cardiovascular and cerebrovascular diseases and cancer.
• Having therapy for obesity in the last three months.
• The individuals do not adhere to the treatment or are with other treatments.
• Female individuals with pregnancy, lactation and planning a pregnancy in the two months.
• Critical patients or patients combined with liver and kidney damage.
• Individuals with visual and auditory memory disorders or psychosis.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
body mass index(BMI)	2 month after treatment

Secondary Outcome Measures

Name	Time	Method
Triglycerides	2 month after treatment
waist-to-hip ratio (WHR)	2 month after treatment
Blood sugar	2 month after treatment
Total cholesterol	2 month after treatment
High-density lipoprotein cholesterol	2 month after treatment
Low-density lipoprotein cholesterol	2 month after treatment

Trial Locations

Locations (1)

The First Affiliated Hospital of Heilongjiang University of Chinese Medicine; 🇨🇳 Harbin, Heilongjiang, China